Article information
Full text is only aviable in PDF
Bibliografía
[1.]
M. Miravitlles, C. Murio, T. Guerrero, R. Gisbert.
Costs of chronic bronchitis and COPD. A one year follow-up study.
Chest, 123 (2003), pp. 784-791
[2.]
J.L. Izquierdo Alonso, J. De Miguel Díez.
Economic impact of pulmonary drugs on direct costs of stable chronic obstructive pulmonary disease.
Journal of COPD, 1 (2004), pp. 215-233
[3.]
D.E. Hilleman, N. Dewan, M. Malesker, M. Friedman.
Pharmacoeconomic evaluation of COPD.
Chest, 118 (2000), pp. 1278-1285
[4.]
R. Dahl, C.G. Lofdahl, The economic impact of COPD in North America and Europe.
Analysis of the Confronting COPD survey.
Respir Med, 97 (2003), pp. 1-2
[5.]
R. Rodríguez-Roisin, J.L. Álvarez-Sala, V. Sobradillo.
2002: un buen año capicúa para la EPOC.
Arch Bronconeumol, 38 (2002), pp. 503-505
[6.]
B.R. Celli.
The importance of spirometry in COPD and asthma: effect on approach to management.
Chest, 117 (2000), pp. 15-19
[7.]
J.A. Barberà, G. Peces-Barba, A.G.N. Agustí, J.L. Izquierdo, E. Monsó, T. Montemayor, et al.
Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 37 (2001), pp. 297-316
[8.]
N.M. Siafakas, P. Vermeire, N.B. Pride, P. Paoletti, J. Gibson, P. Howard, et al.
Optimal assessment and management of chronic obstructive pulmonary disease (COPD).
Eur Respir J, 8 (1995), pp. 1398-1420
[9.]
R.A. Pauwels, A.S. Buist, P.M. Calverley, C.R. Jenkins, S.S. Hurd.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary.
Am J Respir Crit Care Med, 163 (2001), pp. 1256-1276
[10.]
G.T. Ferguson, P.L. Enright, A.S. Buist, M.W. Higgins.
Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program.
Chest, 45 (2000), pp. 1146-1161
[11.]
V. Sobradillo Peña, M. Miravitlles, R. Gabriel, C.A. Jiménez-Ruiz, C. Villasante, J.F. Masa, et al.
Geographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study.
Chest, 118 (2000), pp. 981
[12.]
D.B. Coultas, D. Mapel, R. Gagnon, E. Lydick.
The health impact of undiagnosed airflow obstruction in a national sample of United States adults.
Am J Respir Crit Care Med, 164 (2001), pp. 372-377
[13.]
J. Hueto, P. Cebollero, I. Pascal, J.A. Cascante, V.M. Eguía, F. Teruel, et al.
La espirometría en atención primaria en Navarra.
Arch Bronconeumol, 42 (2006), pp. 325-330
[14.]
J. Giner, P. Casan, M.A. Berrogalviz, F. Burgos, V. Macian, J. Sanchis.
Cumplimiento de las “recomendaciones SEPAR” sobre la espirometría.
Arch Bronconeumol, 32 (1996), pp. 516-522
[15.]
De Miguel Díez J, Izquierdo Alonso JL, Molina Paris J, Rodríguez González-Moro JM, De Lucas Ramos P, Gaspar Alonso-Vega G. Fiabilidad del diagnóstico de la EPOC en la atención primaria y neumología en España. Factores predictivos. Arch Bronconeumol. 2003;39:203-8.
[16.]
American Thoracic Society.
Standardization of spirometry: 1994 update.
Am J Crit Care Med, 152 (1995), pp. 1107-1136
[17.]
T. Eaton, S. Withy, J.E. Garrett, J. Mercer, R.M. Whitlock, H.H. Rea.
Spirometry in primary care practice. The importance of quality assurance and the impact of spirometry workshops.
Chest, 116 (1999), pp. 416-423
[18.]
E. López de Santa María, L. Gutiérrez, C. Legorburu, M. Valero, M. Zabala, V. Sobradillo, J.B. Galdiz.
Calidad de la espirometría en las consultas neumológicas de un área jerarquizada.
Arch Bronconeumol, 38 (2002), pp. 204-208
[19.]
R. Pérez-Padilla, G. Valdivia, A. Muiño, M.V. López, M.N. Márquez, M. Montes de Oca, et al.
Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad.
Arch Bronconeumol, 42 (2006), pp. 317-324
[20.]
A.M. Menezes, R. Pérez-Padilla, J.R. Jardim, A. Muino, M.V. López, G Valdivia, et al.
PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study.
Lancet, 366 (2005), pp. 1875-1881
[21.]
J.L. Hankinson, J.R. Odencrantz, K.B. Fedan.
Spirometric reference values from a sample of the general U.S. population.
Am J Respir Crit Care Med, 159 (1999), pp. 179-187
[22.]
J. Roca, F. Burgos, J. Sunyer, M. Sáez, S. Chinn, J.M. Antó, et al.
References values for forced spirometry. Group of the European Community Respiratory Health Survey.
Eur Respir J, 11 (1998), pp. 1354-1362
[23.]
R.O. Crapo, A.H. Morris, R.M. Gardner.
Reference spirometric values using techniques and equipment that meet ATS recommendations.
Am Rev Respir Dis, 123 (1981), pp. 659-664
[24.]
P.L. Enright, A.B. Adams, P.J. Boyle, D.L. Sherrill.
Spirometry and maximal respiratory pressure references from healthy Minnesota 65- to 85-year-old women and men.
Chest, 108 (1995), pp. 663-669
[25.]
P.H. Quanjer.
Standardized lung function testing.
Bull Eur Physiopathol Respir, 19 (1983), pp. 1-95
[26.]
R.J. Knudson, M.B. Lebowitz, C.J. Holberg, B. Burrows.
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Am Rev Respir Dis, 127 (1983), pp. 725-734
[27.]
R. Pellegrino, G. Viegi, V. Brusasco, R.O. Crapo, F. Burgos, R. Casaburi, et al.
Interpretative strategies for lung function tests.
Eur Respir J, 26 (2005), pp. 948-968
[28.]
P.L. Enright, K.C. Beck, D.L. Sherrill.
Repeatability of spirometry in 18,000 adult patients.
Am J Respir Crit Care Med, 169 (2004), pp. 235-238
[29.]
M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, et al.
Standardisation of spirometry.
Eur Respir J, 26 (2005), pp. 319-338
[30.]
PLATINO-ALAT. Disponible en: http://www.platino-alat.org/
[31.]
J. Finkelstein, M. Cabrera, G. Hripcsak.
Internet-based home asthma telemonitoring. Can patients handle the technology?.
Chest, 117 (2000), pp. 148-155
[32.]
B. Morlion, C. Knoop, M. Pavia, M. Estenne.
Internet-based home monitoring of pulmonary function after lung transplantation.
Am J Respir Crit Care Med, 165 (2002), pp. 694-697
[33.]
F. Burgos, C. Gistau, T. Serrano, L. García, G. Brunet, C. Hernández, et al.
Reliability of forced spirometry in primary care (PC): assessment of the impact of a remote assistance program.
Proceedings of the American Thoracic Society, V2 (2005), pp. A35
[34.]
Unifying efforts in the global fight against lung disease. Disponible en: http://www.ersnet.org/ers/show/default.aspx?id_attach=10629
Estudio subvencionado en parte por Red Respira ISC III (RTIC-03/11), Fondo de Investigación Sanitaria (FIS 042728) y MAPFRE 2006.
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica
